Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06871423 · ClinicalTrials.gov registry record · NA

The Effect of Virtual Reality on Pain and Memory.

A NA study of Healthy Adult, sponsored by University of Washington.

Completed
Registry status
NA
Development phase
16
Enrollment target
1
Study location

NCT06871423: Completed NA study of Healthy Adult, sponsored by University of Washington.

NCT06871423 is a NA study of Healthy Adult that has completed, run by University of Washington. The registered enrollment target is 16 participants, below the 72-participant average among 8 other Healthy Adult trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06871423, a NA study of Healthy Adult, has completed, sponsored by University of Washington.

COMPLETED
Registry status
NA
Development phase
16 participants
Enrollment target
1
Study location

Study Summary

The effect of Virtual Reality on pain and memory.

Primary Outcome

After each brief thermal stimulus set, participants were asked to recall the exact pattern of the most recent sequence of 5 brief thermal stimuli, recalled in exact order, via our five question "pain memory recall test" (min = 0%, max -= 100% correct). Lower % correct scores mean less accurate memory (poorer outcome).

Conditions Studied

Interventions

  • BEHAVIORAL distraction

Study Locations (1)

Washington

  • University of Washington - Seattle

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2025-01-03
Est. Completion 2025-03-01
Phase NA
University of Washington

1,048 total trials

What the finished NCT06871423 record still lists

NCT06871423 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 72-participant average among 8 other Healthy Adult trials with a reported enrollment target (78% lower).

The record links to 1 condition, with Healthy Adult appearing as the primary indexed condition, and to 1 intervention - of which distraction is the first listed.

NCT06871423 reports a single indexed study location in Washington.

Frequently Asked Questions

What is clinical trial NCT06871423 about?

NCT06871423 is a clinical study titled "The Effect of Virtual Reality on Pain and Memory.". The effect of Virtual Reality on pain and memory.

What is the current status of trial NCT06871423?

This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2025-01-03. Estimated completion is 2025-03-01.

What conditions does trial NCT06871423 study?

This clinical trial studies the following conditions: Healthy Adult.

What interventions are being tested in trial NCT06871423?

The interventions under investigation include: distraction (BEHAVIORAL).

Who is sponsoring clinical trial NCT06871423?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06871423 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy Adult

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06871423's enrollment target sits among peer trials

16 8th of 8 higher than 1 of 8 other Healthy Adult trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Healthy Adult trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02422641 · 16 participants · Phase 2

    Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis

  • NCT02851758 · 16 participants · NA

    Transplantation of Autologously Derived Mitochondria Following Ischemia

  • NCT03291028 · 16 participants

    Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma

  • NCT03425526 · 16 participants · Phase 1

    Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06871423, the US trial registry maintained by the National Library of Medicine. NCT06871423 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.